Compare Nu Holdings Ltd (NU) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

NU Holdings stock trades at $15.33, down slightly by 0.26% today, with a bullish technical signal from moving averages and a consensus analyst price target of $17.20. The company reported strong Q2 2026 results, including a 39% revenue growth and record net income exceeding $1 billion, driven by expanding customer base and AI integration. Cash flow from operations reached $3.5 billion in 2025, supporting robust financial health.

Outlook remains positive with growth opportunities in Mexico and AI-driven efficiencies, but risks include credit quality concerns and competitive pressures. Analysts are predominantly bullish, with 57% recommending buy, though investors should monitor debt levels and macroeconomic factors affecting fintech sectors.

Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.

The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.